Hydroxychloroquine clinical trial begins

More than 40,000 healthcare workers around the world on Thursday began participating in University of Oxford-led international clinical trials of two anti-malarial drugs to see if they can prevent COVID-19. The drugs are chloroquine and hydroxychloroquine.

Invest in the
Trusted Mideast
News source.
We are on the
front lines.

Personalize Your News
Upgrade your experience by choosing the categories that matter most to you.
Click on the icon to add the category to your Personalize news
Browse Categories and Topics
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.